Sun Pharma Q2 Results: Profit falls 36% YoY to Rs 1,989 crore on exceptional charges

Sun Pharma reported a 36% year-on-year decline in profit for the second quarter, with earnings coming in at Rs 1,989 crore.

Exceptional charges weigh on earnings

The result was reported in the context of exceptional charges, which accompanied the quarter's lower profit. The available information does not provide further details on the nature or value of those charges.

Key figure

• Second-quarter profit: Rs 1,989 crore
• Year-on-year change: 36% decline

The result places the focus on Sun Pharma's quarterly earnings and the impact of exceptional items on reported profitability. No additional financial or operational details were provided.